Perioperative Management In Patients With Long-Term Steroid Use by Ekadamayanti, Agustia Sukri et al.
Journal of Endocrinology, Tropical Medicine, and Infectiouse Disease (JETROMI) Vol. 02, No. 1, 2020 / 17-24 
 
 
*Corresponding author at: Division of Endocrinology, Metabolism and Diabetes, Department of Internal Medicine,  
Universitas  Syiah Kuala School of Medicine- dr.Zainoel Abidin General Teaching Hospital, Banda Aceh, Indonesia  
 
E-mail address: agustiasukri@gmail.com 
 
Copyright © 2020 Published by Talenta Publisher  
ISSN: 2686-0872 | e-ISSN: 2686-0856 | DOI: 10.32734/jetromi.v2i1.2061 
Journal Homepage: https://jetromi.usu.ac.id 
PERIOPERATIVE MANAGEMENT IN PATIENTS 
WITH LONG-TERM STEROID USE  
Agustia Sukri Ekadamayanti1, Hendra Zufry1, Krishna W Sucipto1 
1Division of Endocrinology, Metabolism and Diabetes, Department of Internal Medicine,  Universitas  
Syiah Kuala School of Medicine- dr.Zainoel Abidin General Teaching Hospital, Banda Aceh, Indonesia 
 
Abstract. Systemic corticosteroid given with oral or parenteral route is widely used in the 
treatment of various condition and has potent anti-inflammatory, imunomodulatory, and 
anti-neoplastic effect. Although steroid has potentially clinical benefit effects, long-term 
use of this regiment also associated with several serious risks and may deteriorate life 
quality and high cost management. Long-term steroid use may alter our body response to 
stress due to HPA Axis suppression. Surgical procedure will increase stress in our body, 
which can lead into higher demand of cortisol. When surgery performed, a signal from the 
operation site through afferent nerve will activate hypothalamus to release corticotropin 
releasing hormone, that will stimulate cortisol hypersecretion. Preoperative management 
guidelines recommend the use of stress dose or supplementation dose for patient with long-
term steroid use, which will be discussed further in this review article with additional case 
illustration.  
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Abstrak. Kortikosteroid sistemik yang diberikan dengan rute oral atau parenteral banyak 
digunakan dalam pengobatan berbagai kondisi dan memiliki efek antiinflamasi, 
imunomodulator, dan anti neoplastik yang kuat. Meskipun steroid berpotensi memiliki efek 
manfaat klinis, penggunaan jangka panjang resimen ini juga dikaitkan dengan beberapa 
risiko serius dan dapat menurunkan kualitas hidup dan manajemen biaya tinggi. 
Penggunaan steroid jangka panjang dapat mengubah respons tubuh kita terhadap stres 
karena penekanan HPA Axis. Prosedur bedah akan meningkatkan stres di tubuh kita, yang 
dapat menyebabkan permintaan kortisol yang lebih tinggi. Ketika operasi dilakukan, sinyal 
dari tempat operasi melalui afferent nervus akan mengaktifkan hipotalamus untuk 
melepaskan hormon pelepas kortikotropin, yang akan merangsang sekresi hiper kortisol. 
Pedoman manajemen pra operasi merekomendasikan penggunaan dosis stres atau dosis 
suplemen untuk pasien dengan penggunaan steroid jangka panjang, yang akan dibahas 
lebih lanjut dalam tinjauan pustaka ini beserta ilustrasi kasus. 
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1 Introduction 
Systemic corticosteroid given with oral or parenteral route, for examples prednisone, 
prednisolone, methyl prednisolone and dexamethasone has potent anti-inflammatory, 
imunomodulatory, and anti-neoplastic effect and is widely use in the treatment of various 
condition, including autoimmune diseases, allergic reactions, asthma exacerbation, chronic 
pulmonary obstructive disease also malignancies. Although steroid has potentially clinical 
benefit effects, long-term use of these regiment also associated with several serious risk like 
osteoporosis, cardiovascular disease, impaired immune response and prolong wound healing, 
alteration of lipid and glucose metabolism and psychiatric disturbance. Such complications may 
deteriorate life quality and highly cost management.[1] Surgical procedure will increase stress 
in our body, which can led into higher demand of cortisol. When surgery performed, a signal 
from the operation site through afferent nervus will activate hypothalamus to release 
corticotropin releasing hormone, that will stimulate cortisol hypersecretion.[2,3]  
Long-term use of steroid will decrease cortisol respond to stress and dose duration use of 
glucocorticoid has correlation with adrenal suppression.[4] We will reperesent a case of a 
woman with long term steroid use that will undergo surgery. 
2 Case Ilustration   
A 38 years old female patient, Mrs.RZ, has been diagnosed with pemphigus vulgasris since 
2011 and has been treated with corticosteroid. The dose has been reduced from 125 mg/day 
prednisone to 64 mg/day methylprednisolone, and now she routinely consume 8 mg methyl 
prednisolone 3 times a week for more than 3 month. She was also diagnosed with  myoma utery 
and was planned to have total hysterectomy, the obstetry and gynecology department consult to 
endocrinology division for pre-operative management due to prolong steroid use. 
The vital sign are within normal limits. We found moon face, but there was no buffalo hump 
and red striae on her abdomen. Her cardio and pulmonary physical examination was normal. 
There was palpable lump in her abdomen. On laboratory examination we found normal routine 
blood, electrolyte, blood glucose and kidney function measurements. 
How does the perioperative management of this patient with long-term steroid use in 
endocrinology point of view?    
3 Discussion 
Secretion and synthesis of glucocorticoid (cortisol) hormones by the adrenal cortex are 
predominantly affected by adrenocorticotropic hormone (ACTH) secreted by the anterior 
pituitary under the influence of the corticotropin-releasing hormone (CRH) produced in the 
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hypothalamus. ACTH and CRH regulate cortisol secretion through a negative feedback 
mechanism.[5] The normal production of cortisol is in the range of 15-20 mg per day.[6] 
The main functions of cortisol are: 1) Control the metabolism of carbohydrate proteins and fats; 
2) Suppression of inflammatory tissue processes in response to injury; 3) Suppression of 
immune responses to foreign antigens; 4) Increase the body's ability to withstand various stimuli 
that endanger (stress).[7] 
Steroid use may cause iatrogenic Adrenal Insufficiency (AI) which caused by suppression of the 
HPA axis due to the use of glucocorticoids at therapeutic doses. Degree of HPA axis 
suppression and adrenal atrophy in patients receiving exogenous glucocorticoids is related to the 
duration and dosage of the drug. However, several studies have shown a low correlation 
between HPA axis function and cumulative dose, the largest dose or duration of therapy. 
Because of the considerable inter-individual variability in the degree and duration of adrenal 
suppression, it is difficult to accurately predict which patients will develop into AI when 
glucocorticoid treatment is stopped. Several case reports that have been published regarding 
steroid induced adrenal insufficiency do not provide sufficient information to be used as a 
reference for clinical diagnosis of HPA axis suppression and the risk of AI. They were unable to 
determine the duration of steroid therapy use that will make adrenal suppression become overt, 
how much the dose could cause adrenal suppression and how long does it take for HPA Axis 
recovery after the cessation of glucocorticoids.[8] However, it is simply believed that for 
patients taking steroids at any dose less than 3 weeks, the suppression of the HPA axis is not 
clinically significant. Conversely, patients taking steroid doses which are equivalent to 
prednisolone 15 mg/day for more than three weeks should be suspected for having the HPA axis 
suppression.[9] 
Hormonal responses to surgery, critical condition, and trauma have been widely studied over the 
past 20 years. Plasma ACTH, plasma cortisol concentrations, free cortisol urine, and urinary 
cortisol concentrations increases in response to surgery, trauma, and other forms of critical 
illness.[10] Surgery is a stressor that can be categorized base on duration and severity level and 
may induce a systemic response for stress which includes an increase in adrenal cortisol 
production.[3] 
When stress occurs and the hypothalamus is stimulated, CRH is released. CRH then stimulates 
ACTH release from the anterior pituitary, that will cause  an increase in glucocorticoid synthesis 
in the adrenal cortex. In surgery, the main mechanism responsible for cortisol hypersecretion as 
response to stress is preceded by afferent nerve signals obtained from the surgical site which 
then stimulates the hypothalamus to release the corticotropin hormone and arginine vasopressin. 
These two peptides then stimulate the secretion of the adenocorticotropic hormone from the 
anterior pituitary, which stimulates cortisol secretion by the adrenal cortex.[2] 
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Under normal conditions, the adrenal glands from healthy adults produces cortisol as much as 
10-20 mg/day and in a stress full state, cortisol hormone secretion will increase around 150 
mg/day.[11] Then in a state of long-term steroid use, adrenal suppression or HPA Axis 
suppression may occur, hence the natural response of endogenous cortisol to stress cannot 
achieved resulting in adrenal insufficiency. 
Preoperative Management in Patients with Long-term Steroid Use  
Surgery make’s our body to be in a state of stress, thus requiring greater cortisol. The use of 
corticosteroids at a dose of 20-30 mg of prednisone per day for more than 1 week should be 
suspected of having adrenal or HPA Axis suppression. Thus the preoperative guidelines 
recommends steroid supplementation for preoperative patients. Guidelines by Salem, et al.  [10], 
requirement of preoperative steroid supplementation in patients with long-term steroid use in 
minor, moderate or major surgery which dose adjusted based on the type of surgery and 
estimated steroid dose requirements based on the stress arising from surgery. However, a study 
conducted by Groleau et al. [12] which objective is to the determine whether the administration 
of perioperative corticosteroids, compared with placebo or without intervention, reduces the 
incidence of adrenal insufficiency in adult patients exposed to corticosteroids and undergo non-
cardiac surgery. The results of the study found that corticosteroid stress-dose in perioperative 
therapy may not be needed as an addition to the patient's daily steroid dose and the patient's 
daily steroid dose is sufficient in some cases. This review concludes that the current widespread 
practice of providing supra-physiological corticosteroid supplementation in perioperative 
management of patient who have used steroids before, was not supported by sufficient 
literature. In another study conducted by Prete et al. [3] found that the cortisol response was 
significantly different between patients undergoing minimally invasive (grade I) surgery 
compared to patients undergoing moderate and high invasive surgery (grade II and III). 
Interestingly, grade I surgery did not cause an increase in peri-operative cortisol. In grade II and 
III operations there was no significant differences cortisol elevation level during extubation and 
18 hours after surgery. And that increase in cortisol lasts until 1 week after surgery.  
The existing perioperative guidelines divide the condition of patients using steroids into 3 
categories; the very unlikely group, the intermediate group or the unknown group and the very 
likely group experienced HPA Axis suppression. Patients who are very unlikely to have HPA 
axis suppression are a group of patients receiving glucocorticoid therapy with dose of 5 mg /day 
or less prednisone or equivalent, or getting steroid therapy for less than 3 weeks. Patients in this 
group has low risk and may continue the usual daily dose and do not requiring steroid 
supplementation or stress doses steroid. Patients in this group also do not need a supportive 
examination to assess adrenal function, unless the results of the examination can change their 
perioperative management. Blood pressure monitoring alone is sufficient. Patients who are 
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known to have HPA axis suppression or have a high risk are patients receiving glucocorticoids 
at a dose of 20 mg/day or more prednisone or equivalent for more than 3 weeks, or the group 
receiving glucocorticoid therapy due to primary adrenal insufficiency or cushing syndromes 
which is clearly considered to have a high risk suppression of the HPA axis. This group must 
have preoperative steroid supplementation. Patients in the intermediate group or unknown risk 
of HPA axis suppression were not included in the low or high risk categories as previously 
mentioned. This group is patients that is being or have received prednisone therapy at a dose of 
5-20 mg / day or equivalent for more than 3 weeks in the past year. Patients in this group tend to 
have wide variations in HPA axis suppression and need to undergo an examination to assess the 
HPA axis.[13]  
When preoperative evaluation is needed, a short ACTH stimulation test is an option for 
assessing the integrity and function of the HPA axis. This test is done by giving 250 μg 
cortrosyn in the morning after the patient overnight  fast and blood samples is taken to be tested 
for  baseline ACTH and cortisol. At minute 30 and 60 after the injection, the sample was taken 
again for cortisol examination. If the response is normal (increase ≥ 18 µg / dL), then no further 
evaluation is required, nor the dose of steroid supplementation/stress dose steroid. Other tests 
that can be done are the insulin-induced hypoglycaemia or low-dose ACTH (1 µg) examination, 
but this methode is more difficult and with high risk, so the cortrosyn test is an option to do, 
although this examination also has limitations. Because this examination only assessed total 
serum cortisol levels rather than serum free cortisol which plays a role in the physiological 
effects of cortisol.[14]  
The recommended stress dose or supplementation dose of steroid were based on type of surgery; 
superficial surgery (ex. dental surgery or biopsy) use the usual daily dose. Minor surgery (ex. 
Inguinal hernia repair, colonoscopy, uterine curettage, hand surgery), and moderate surgery (ex. 
total joint replacement, colon resection)  use the daily dose plus hydrocortisone 50 mg IV before 
incision continue with hydrocortisone 25 mg IV every 8 hour x 24 hour, then usual daily dose. 
for major surgery (ex. major cardiac/vascular) use usual daily dose plus hydrocortisone 100 mg 
before incision followed by continuous IV infusion of 200 mg hydrocortisone more than 24 
hour or hydrocortisone 50 mg IV every 8 h x 24 h taper dose by half per day until usual daily 
dose reached plus continuous IV fluids with 5% dextrose and 0,2-0,45% NaCl (Based on degree 
of hypoglycaemia).[14] 
4  Conclusion 
Long-term steroid use may result in iatrogenic adrenal insufficiency, due to HPA-Axis 
supression 
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Stress due to surgical procedure may increase the need of cortisol, which in long-term steroid 
use patients cannot be secreted due to adrenal insufficiency  
Patient in case illustration is recommended to continue her preoperative steroid dose as usual 
and continued until postoperative periode. It’s not recommended to add stress dose or 
supplementation dose, since this patient daily steroid dose does not exceed 10 mg/day 
prednisone or equivalent or with low risk category. No need to measure HPA Axis, since this 
patient use low dose steroid for more than 3 weeks. We need to monitor postoperative 
hemodynamic if hypotension and symptoms of acute adrenal insufficiency occur, steroid 
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